NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 113662-23-0
Drug Levels and Effects
Summary of Use during Lactation
There is no published experience with gadobenate during breastfeeding. Gadobenate has been safely used in infants, so it does not appear to pose a substantial risk to a breastfed infant.[1] Guidelines developed by several North American professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a gadolinium-containing contrast medium.[2][3][4]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- Fraum TJ, Ludwig DR, Bashir MR et al. Gadolinium-based contrast agents: A comprehensive risk assessment. J Magn Reson Imaging. 2017;46:338-53. [PubMed: 28083913]
- 2.
- American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2017;Version 10.3:102-3. https://www
.acr.org/~ /media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf. - 3.
- Patenaude Y, Pugash D, Lim K et al. The use of magnetic resonance imaging in the obstetric patient. J Obstet Gynaecol Can. 2014;36:349-55. [PubMed: 24798674]
- 4.
- Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017;130:e210-e216. [PubMed: 28937575]
Substance Identification
Substance Name
Gadobenate
CAS Registry Number
113662-23-0
Drug Class
- Breast Feeding
- Contrast Media
- Diagnostic Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Gadopentetate[Drugs and Lactation Database (...]Review Gadopentetate. Drugs and Lactation Database (LactMed). 2006
- Review Ioxaglate[Drugs and Lactation Database (...]Review Ioxaglate. Drugs and Lactation Database (LactMed). 2006
- Review Gadoversetamide[Drugs and Lactation Database (...]Review Gadoversetamide. Drugs and Lactation Database (LactMed). 2006
- Review Gadoxetate[Drugs and Lactation Database (...]Review Gadoxetate. Drugs and Lactation Database (LactMed). 2006
- Review Alendronate[Drugs and Lactation Database (...]Review Alendronate. Drugs and Lactation Database (LactMed). 2006
- Gadobenate - Drugs and Lactation Database (LactMed)Gadobenate - Drugs and Lactation Database (LactMed)
Your browsing activity is empty.
Activity recording is turned off.
See more...